NASDAQ:NLNK - NewLink Genetics Stock Price, Forecast & News

NewLink Genetics trades on the NASDAQ under the ticker symbol "NLNK."

NewLink Genetics Corp (NASDAQ:NLNK) announced its earnings results on Wednesday, November, 6th. The biotechnology company reported ($0.27) earnings per share for the quarter, hitting the consensus estimate of ($0.27). The biotechnology company had revenue of $0.25 million for the quarter. NewLink Genetics had a negative net margin of 6,423.69% and a negative return on equity of 40.06%. View NewLink Genetics' Earnings History.

NewLink Genetics is scheduled to release their next quarterly earnings announcement on Wednesday, February 26th 2020. View Earnings Estimates for NewLink Genetics.

2 brokers have issued 1-year target prices for NewLink Genetics' shares. Their forecasts range from $4.00 to $4.00. On average, they anticipate NewLink Genetics' share price to reach $4.00 in the next year. This suggests a possible upside of 96.1% from the stock's current price. View Analyst Price Targets for NewLink Genetics.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for NewLink Genetics in the last year. There are currently 1 sell rating and 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for NewLink Genetics.

News coverage about NLNK stock has been trending somewhat positive on Saturday, according to InfoTrie Sentiment Analysis. The research firm ranks the sentiment of press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. NewLink Genetics earned a news impact score of 1.5 on InfoTrie's scale. They also assigned media headlines about the biotechnology company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View News Stories for NewLink Genetics.

NewLink Genetics saw a increase in short interest in the month of December. As of December 13th, there was short interest totalling 1,720,000 shares, an increase of 6.2% from the November 28th total of 1,620,000 shares. Based on an average daily volume of 500,100 shares, the days-to-cover ratio is currently 3.4 days. Currently, 6.0% of the company's shares are short sold. View NewLink Genetics' Current Options Chain.

Some companies that are related to NewLink Genetics include Amgen (AMGN), Gilead Sciences (GILD), Celgene (CELG), Vertex Pharmaceuticals (VRTX), Biogen (BIIB), Regeneron Pharmaceuticals (REGN), Alexion Pharmaceuticals (ALXN), Seattle Genetics (SGEN), Incyte (INCY), BioMarin Pharmaceutical (BMRN), Alnylam Pharmaceuticals (ALNY), EXACT Sciences (EXAS), Neurocrine Biosciences (NBIX), Ionis Pharmaceuticals (IONS) and Exelixis (EXEL).

Based on aggregate information from My MarketBeat watchlists, some companies that other NewLink Genetics investors own include Arbutus Biopharma (ABUS), Synergy Pharmaceuticals (SGYP), Inovio Pharmaceuticals (INO), SunPower (SPWR), Alibaba Group (BABA), Celldex Therapeutics (CLDX), Sarepta Therapeutics (SRPT), Cara Therapeutics (CARA), Novavax (NVAX) and Opko Health (OPK).

Shares of NLNK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of NLNK stock can currently be purchased for approximately $2.04.

NewLink Genetics has a market capitalization of $76.12 million and generates $12.47 million in revenue each year. The biotechnology company earns $-53,600,000.00 in net income (profit) each year or ($1.44) on an earnings per share basis. NewLink Genetics employs 55 workers across the globe.View Additional Information About NewLink Genetics.

The official website for NewLink Genetics is http://www.newlinkgenetics.com/.

NewLink Genetics' mailing address is 2503 SOUTH LOOP DRIVE, AMES IA, 50010. The biotechnology company can be reached via phone at 515-296-5555 or via email at [email protected]